Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations

Virology

Volumn 230, Issue 1, 1997, Pages 125-133

  Gluschankof, Pablo ^a   Mondor, Isabelle ^a   Gelderblom, Hans R ^b   Sattentau, Quentin J ^a  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS ISOLATION; VIRUS PURIFICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031592609     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8453     Document Type: Article

References (35)

1. Abbate I., Capobianchi M. R., Fais S., Castilletti C., Mercuri F., Cordiali P., Ameglio F., Dianzani F. Host cell antigenic profile acquired by HIV-1 is a marker of its cellular origin. Arch. Virol. 140:1995;1849-1854.
2. Arthur L. O., Bess J. W. Jr., Sowder R. C. D., Benveniste R. E., Mann D. L., Chermann J. C., Henderson L. E. Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines. Science. 258:1992;1935-1938.
3. Arthur L. O., Bess J. W., Urban R. G., Strominger J. L., Morton W. R., Mann D. L., Henderson L. E., Benveniste R. E. Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. J. Virol. 69:1995;3117-3124.
4. Azocar J., Essex M. Incorporation of HLA antigens into the envelope of RNA tumor viruses grown in human cells. Cancer Res. 39:1979;3388-3391.
5. J. W. Bess, R. J. Gorelick, L. E. Henderson, L. O. Arthur, 1997, Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations.
6. Bubbers J. E., Lilly F. Selective incorporation of H-2 antigenic determinants into Friend virus particles. Nature. 266:1977;458-459.
7. Cammarota G., Scheirle A., Takacs B., Doran D. M., Knorr R., Bannwarth W., Guardiola J., Sinigaglia F. Identification of a CD4 binding site on the beta 2 domain of HLA DR molecules. Nature. 356:1992;799-810.
8. Cantin R., Fortin J.-F., Tremblay M. The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. Virology. 218:1996;372-381.
9. Chan W. L., Rodgers A., Grief C., Almond N., Ellis S., Flanagan B., Silvera P., Bootman J., Stott J., Kent K., Bomford R. Immunization with class-I human histocompatibility leucocyte antigen can protect macaques against challenge infection with SIVmac-32H. AIDS. 9:1995;223-228.
10. Cheng-Mayer C., Seto D., Levy J. A. Altered host range of HIV-1 after passage through various human cell types. Virology. 181:1991;288-294.
11. Desrosiers R. C., Wyand M. S., Kodama T., Ringler D. J., Arthur L. O., Sehgal P. K., Letvin N. L., King N. W., Daniel M. D. Vaccine protection against simian immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA. 86:1989;6353-6357.
12. Fisher A. G., Ensoli B., Looney D., Rose A., Gallo R. C., Saag M. S., Shaw G. M. Biologically diverse molecular variants within a single HIV-1 isolate. Nature. 334:1988;444-447.
13. Gelderblom H. Assembly and morphology of HIV: Potential effect of structure on viral function. AIDS. 5:1991;617-638.
14. Gelderblom H., Reupke H., Winkler T., Kunze R., Pauli G. MHC antigens: Constituents of the envelopes of human and simian immunodeficiency viruses. Z. Naturforsch. 42:1987;1328-1334.
15. Girard M., Kieny M. P., Pinter A., Barre-Sinoussi F., Nara P., Kolbe H., Kusumi K., Chaput A., Reinhart T., Muchmore E. Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 88:1991;542-546.
16. Henderson L. E., Sowder R., Copeland T. D., Oroszlan S., Arthur L. O., Robey W. G., Fischinger P. J. Direct identification of class-II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III. J. Virol. 61:1987;629-632.
17. Hoxie J. A., Fitzharris T. P., Youngbar P. R., Matthews D. M., Rackowski J. L., Radka S. F. Nonrandom association of cellular antigens with HTLV-III virions. Hum. Immunol. 18:1987;39-52.
18. Hunter J. B., Menitove J. E. HLA antibodies detected by ELISA HTLV- III antibody kits. Lancet. ii:1985;397.
19. Kuhnl P., Seidl S., Holzberger G. HLA DR4 antibodies cause positive HTLV-III antibody ELISA results. Lancet. i:1985;1222-1223.
20. Lando Z., Sarin P., Megson M., Greene W. C., Waldman T. A., Gallo R. C., Broder S. Association of human T cell leukemia/lymphoma virus with the Tac antigen marker for the human T cell growth factor receptor. Nature. 305:1983;733-735.
21. Lee T. H., Essex M., De Noronha F., Azocar J. Neutralization of feline leukemia virus with feline antisera to leukocyte alloantigens. Cancer Res. 42:1982;3995.
22. Levy J. HIV and the Pathogenesis of AIDS. 1994;Am. Soc. Microbiol. Washington.
23. Meerloo T., Sheikh M. A., Bloem A. C., de Ronde A., Schutten M., van Els C. A. C., Roholl P. J. M., Joling P., Goudsmit J., Schuurman H.-J. Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells: An immunoelectron microscopic study. J. Gen. Virol. 74:1993;129-135.
24. Miyake K., McNeil P. L. Vesicle accumulation and exocytosis at sites of plasma membrane disruption. J. Cell Biol. 131:1995;1737-1745.
25. Moore J. P., Jameson B. A., Weiss R. A., Sattentau Q. J. The HIV-cell fusion reaction. Viral Fusion Mechanisms. 1993;CRC Press, Boca Raton. p. 233-291.
26. Moore J. P., McKeating J. A., Weiss R. A., Sattentau Q. J. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science. 250:1990;1139-1142.
27. Morein B., Helenius A., Simons K., Pettersson R., Kaariainen L., Schirrmacher V. Effective subunit vaccines against an enveloped animal virus. Nature. 276:1978;715-718.
28. Morein B., Sundquist B., Hoglund S., Dalsgaard D., Osterhaus A. ISCOM, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature. 308:1984;457-460.
29. Murphey-Corb M., Martin L. N., Davidson-Fairburn B., Montelaro R. C., Miller M., West M., Ohkawa S., Baskin G. B., Zhang J.-Y., Putney S. D., Allison A. C., Eppstein A. A formalin-inactivated whole SIV vaccine confers protection in macaques. Science. 246:1989;1293-1287.
30. Pan B. T., Teng K., Wu C., Adam M., Johnstone R. M. Electron microscopic evidence for externalisation of the transferrin receptor in vesicular form in sheep reticulocytes. J. Cell Biol. 101:1985;942-948.
31. Raposo G., Nijman H. W., Stoorvogel W., Leijendekker R., Harding C. V., Melief C. J. M., Geuze H. J. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183:1996;1161-1172.
32. Rosen A., Casciola-Rosen L., Ahearn J. Novel packages of viral and self antigens are generated during apoptosis. J. Exp. Med. 181:1995;1557-1561.
33. Sattentau Q. J., Weiss R. A. The CD4 antigen: Physiological ligand and HIV receptor. Cell. 52:1988;631-632.
34. Scheirle A., Takacs B., Kremer L., Marin F., Sinigaglia F. Peptide binding to soluble HLA-DR molecules produced by insect cells. J. Immunol. 149:1992;1994-1999.
35. Schols D., Pauwels R., Desmyter J., De Clercq E. Presence of class-II histocompatibility DR proteins on the envelope of human immunodeficiency virus demonstrated by FACS analysis. Virology. 189:1992;374-376.